Lista de obras -

Androgen receptor agonism promotes an osteogenic gene program in preadipocytes

scientific article published on 06 April 2013

Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer

artículo científico publicado en 2020

BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients

artículo científico publicado en 2012

Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends

artículo científico publicado en 2019

Correction: Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression

artículo científico publicado en 2020

Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial

scientific article published on 02 March 2019

Dosimetric effects of weight loss or gain during volumetric modulated arc therapy and intensity-modulated radiation therapy for prostate cancer

artículo científico publicado en 2013

Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy

artículo científico publicado en 2012

Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression

scientific article published on 05 August 2019

Feed-forward inhibition of androgen receptor activity by glucocorticoid action in human adipocytes.

artículo científico publicado en 2012

Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif

scientific article published on January 2013

Improvement in prostate cancer survival over time: a 20-year analysis

artículo científico publicado en 2012

Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer

artículo científico publicado en 2016

Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?

scientific article published on 24 July 2012

Is treatment of the primary tumor in metastatic prostate cancer justified?

artículo científico publicado en 2013

Local recurrence map to guide target volume delineation after radical prostatectomy

artículo científico publicado en 2014

Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial

artículo científico publicado en 2017

Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation

artículo científico publicado en 2013

Mitochondrial Activity in Human White Adipocytes Is Regulated by the Ubiquitin Carrier Protein 9/microRNA-30a Axis

artículo científico publicado en 2016

Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer

scientific article published on 19 November 2018

PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era.

artículo científico publicado en 2012

Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial

artículo científico publicado en 2018

Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy

artículo científico publicado en 2020

Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes

artículo científico publicado en 2017

Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?

artículo científico publicado en 2012

Proton Beam Therapy for Localized Prostate Cancer: Results from a Prospective Quality-of-Life Trial

artículo científico publicado en 2016

Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort.

artículo científico publicado en 2017

Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer

artículo científico publicado en 2013

Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer

artículo científico publicado en 2018

Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial

artículo científico publicado en 2014

Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy

artículo científico publicado en 2012

The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer

artículo científico publicado en 2016

The Landscape of microRNA Targeting in Prostate Cancer Defined by AGO-PAR-CLIP.

scientific article published on June 2016

The miRNA Interactome in Metabolic Homeostasis

artículo científico publicado en 2015

Treatment of recurrent vaginal melanoma with external beam radiation therapy and palladium-103 brachytherapy

artículo científico publicado en 2008

Tumour metabolism and its unique properties in prostate adenocarcinoma

scientific article published on 28 February 2020

Ubc9 Impairs Activation of the Brown Fat Energy Metabolism Program in Human White Adipocytes

artículo científico publicado en 2015

miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in Obesity

artículo científico publicado en 2018

Lista de obras de

Androgen receptor agonism promotes an osteogenic gene program in preadipocytes

Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer

BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients

Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends

Correction: Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression

Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial

Dosimetric effects of weight loss or gain during volumetric modulated arc therapy and intensity-modulated radiation therapy for prostate cancer

Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy

Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression

Feed-forward inhibition of androgen receptor activity by glucocorticoid action in human adipocytes.

Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif

Improvement in prostate cancer survival over time: a 20-year analysis

Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer

Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?

Is treatment of the primary tumor in metastatic prostate cancer justified?

Local recurrence map to guide target volume delineation after radical prostatectomy

Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial

Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation

Mitochondrial Activity in Human White Adipocytes Is Regulated by the Ubiquitin Carrier Protein 9/microRNA-30a Axis

Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer

PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era.

Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial

Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy

Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes

Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?

Proton Beam Therapy for Localized Prostate Cancer: Results from a Prospective Quality-of-Life Trial

Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort.

Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer

Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer

Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial

Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy

The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer

The Landscape of microRNA Targeting in Prostate Cancer Defined by AGO-PAR-CLIP.

The miRNA Interactome in Metabolic Homeostasis

Treatment of recurrent vaginal melanoma with external beam radiation therapy and palladium-103 brachytherapy

Tumour metabolism and its unique properties in prostate adenocarcinoma

Ubc9 Impairs Activation of the Brown Fat Energy Metabolism Program in Human White Adipocytes

miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in Obesity